Immunomodulators: Stimulants and Suppressants
Immunomodulators: Comprehensive Study Notes
Introduction to Immunomodulators
Definition: Immunomodulators are drugs that work at different parts of the immune system to either stimulate or inhibit the immune response.
Key Terms:
Immune Stimulants: Drugs used to boost the body's natural immune system, typically when fighting a long-term infection.
Immune Suppressants: Drugs used to stunt or inhibit the immune system, primarily for organ transplant rejection, autoimmune diseases, and some cancers.
Monoclonal Antibodies (mAbs): Specific antibodies created by one strain of B cells to target specific antigens.
Recombinant DNA Technology: A process that uses bacteria to produce chemicals that naturally occur in the body.
General Considerations for Immunomodulator Therapy
Infection Risk: Patients on immunomodulators, especially suppressants, must be extra careful to avoid infections as their immune system may not eliminate them normally. Family members should also be aware.
Teratogenicity: Immunomodulators were found to be teratogenic in animals. Therefore, they are contraindicated for individuals who could become pregnant or are breastfeeding.
Fertility Effects: These drugs can affect fertility in both men and women. Sperm motility may decrease, and an over-efficient immune system could kill sperm before fertilization.
Administration Techniques (Injections):
When a patient administers an injectable dose, a healthcare professional should watch them after teaching proper technique to ensure correct administration and infection prevention.
Family members should also know how to administer the drug in case the patient cannot self-administer.
Age-Specific Dosing:
Children: Require higher doses due to their body's surface area to weight ratio and faster metabolism.
Older Adults: Have slower metabolism and are more susceptible to adverse effects.
Overall Patient Burden: Receiving immunomodulators is a heavy burden due to increased infection risk, potential renal/hepatic damage, frequent sickness, and the underlying major diagnosis requiring treatment. Mental health considerations are crucial for patient care.
Immune Stimulants
Purpose: Used to boost the immune system, particularly after prolonged infection.
Three Main Types:
. Interferons
Actions:
Prevent the spread of viruses within the body by entering non-infected cells and making antiviral proteins to prevent infection.
Stimulate other immune components like T cells and phagocytes.
Fight tumors and communicate with lymphocytes.
Specific Medication: Interferon alpha-
Therapeutic Uses: Protect cells, slow tumor progression, effective against certain cancers:
Leukemias
Kaposi sarcoma
Malignant melanoma
Follicular lymphoma
Adverse Effects:
Cardiac problems: Arrhythmia, hypertension (use caution in patients with pre-existing cardiac issues).
Myelosuppression: Can exacerbate existing myelosuppression and further decrease bone marrow activity.
Central Nervous System (CNS) Effects: Changes in behavior, CNS depression.
. Interleukins
Actions: Chemicals produced by T cells for communication between leukocytes. Boost immunity by:
Increasing the activity of natural killer cells.
Increasing cytokine production.
Increasing the number of platelets.
Specific Medications:
Aldesleukin: A human interleukin produced by recombinant DNA technology using E. Coli bacteria.
Oprelvekin: A thrombocytopenia growth factor that stimulates stem cells to mature into platelets.
Contraindications:
Pregnancy or lactation.
Renal or hepatic problems (metabolized and excreted by liver and kidneys).
Adverse Effects:
Cardiovascular effects (similar to interferons).
CNS effects.
Flu-like symptoms.
Oprelvekin-specific: High potential for hypersensitivity reactions. Patients must be monitored closely upon initiation and instructed to report chest tightness, trouble breathing, or trouble swallowing immediately.
. Colony Stimulating Factors (CSFs)
Actions: Created using recombinant DNA technology. Used to:
Reduce neutropenia after bone marrow transplantation and chemotherapy.
Assist in treating cancers of the blood.
Specific Medications: Filgrastim and Pegfilgrastim
Contraindications:
Bone marrow cancer or sickle cell disease (will stimulate reproduction of defective cells, worsening the condition).
Sensitivity to E. Coli products (due to recombinant DNA manufacturing).
Concurrent radiation and chemotherapy (can decrease drug effectiveness; typically given after chemotherapy is completed).
Neonates, pregnancy, or breastfeeding (effects are not known).
Adverse Effects (due to bone marrow stimulation and immune activity):
Gastrointestinal: Nausea, vomiting, constipation, diarrhea.
Dermatological: Alopecia, dermatitis (overactive cytokines attacking hair follicles and skin).
Hematological: Splenomegaly (enlarged spleen), leukocytosis (increased white blood cell count; WBC count needs to be monitored).
Nursing Considerations for Immune Stimulants (and General Immunomodulators)
Assessment:
Gather baseline information: Pregnancy status, kidney, liver, or cardiac problems.
Perform baseline assessments: EKG, skin assessment, labs (e.g., CBC, renal/hepatic function), CNS assessment. This helps determine if patients are declining or responding well.
Patient Education:
Thoroughly inform patients about expected adverse effects and how to mitigate them to improve compliance.
Advise use of acetaminophen and adequate hydration to prevent a large portion of adverse effects, especially flu-like symptoms.
Provide detailed education on proper administration technique, especially for injections, to reduce infection risk.
Discuss the increased risk of infection, renal/hepatic damage, and frequent sickness, which can potentially last for life depending on the condition.
Emphasize careful mental health support due to the burden of treatment and underlying diagnoses.
Implementation:
Check lab work regularly throughout treatment to avoid severe adverse effects.
Monitor closely for acute signs of hypersensitivity when patients first start these drugs.
Strongly encourage patients to use barrier methods for contraception, not just hormonal birth control, due to teratogenicity and fertility impact.
Ensure strict adherence to correct aseptic technique for all invasive procedures in these immunocompromised patients.
Evaluation:
Assess if the drug is effectively helping the patient's condition.
Verify patient compliance: Are they taking the drug as directed? If not, investigate reasons (e.g., severe adverse effects).
Evaluate adverse effect severity: Are they manageable with minor adjustments (e.g., acetaminophen and hydration) or do they require further intervention?
Immune Suppressants
Purpose: Used to inhibit the immune system for organ transplant, autoimmune diseases, and some cancers.
Four Main Types:
. Immune Modulators (Specific Class)
Actions: Block the release of various cytokines involved in inflammatory responses and the activation of lymphocytes, thereby decreasing immune activity.
Specific Medication: Apremilast
Therapeutic Uses: Treats psoriatic arthritis (an inflammatory disease) by reducing joint pain and swelling and improving scalp and nail psoriasis.
Adverse Effects/Interactions: As a newer drug class, confirmed adverse effects or drug-to-drug interactions are not yet established.
. T and B Cell Suppressors
Actions: Prevent specific transplant rejections.
Specific Medications: Cyclosporine, Mycophenolate, and Tacrolimus
Cyclosporine-Specific Effects:
Used when patients have had multiple rejection reactions with other T and B cell suppressors being ineffective.
Can cause hirsutism and overgrowth of the gums.
Contraindications:
Known hypersensitivity.
Pregnancy or lactation.
Renal or hepatic problems (can affect drug excretion).
Adverse Effects (serious):
Increased infection risk.
Increased neoplasms (due to decreased immune system ability to fight tumors).
Renal and hepatic toxicity: Requires routine lab monitoring of kidney and liver function. Avoid concurrent administration with other nephrotoxic or hepatotoxic drugs.
. Interleukin Receptor Antagonists
Actions: Blocks interleukin receptors from being stimulated, thereby reducing their immune-boosting effects (antagonist means "less of").
Specific Medication: Anakinra
Therapeutic Uses: Treatment of rheumatoid arthritis when other traditional treatments have not been effective.
Contraindications:
Known reactions to E. Coli products (medication made using recombinant DNA technology and E. Coli).
Pregnancy or lactation.
Active infection.
Renal issues.
Adverse Effects:
Mild pain at the injection site after administration.
Common immunomodulator adverse effects: Flu-like symptoms, GI upset.
Drug-Drug Interactions: Do not combine Anakinra with Etanercept, as this only increases the risk of sepsis without improving disease treatment.
. Monoclonal Antibodies (mAbs)
Naming Convention: Drugs often include "mab" in their names (e.g., MAb: monoclonal anti-body).
Actions: Designed to attach to particular cells, viruses, bacteria, or other antibodies. Many types exist. Those listed here specifically deactivate roaming tumor necrosis factor (TNF), thereby decreasing inflammation.
Therapeutic Uses (wide variety): Cancers, arthritis, Crohn's disease, ulcerative colitis, multiple sclerosis.
Contraindications:
Pregnancy or lactation.
Fluid overload (can be exacerbated by these drugs).
Fever: Treat fevers before administration. It is crucial to determine the cause of the fever: if infection-related, the drug is likely contraindicated; if related to the disease process being treated, it may be given. Requires thorough patient communication and health history assessment.
Adverse Effects:
Most common: Flu-like symptoms.
Most concerning reaction: Acute pulmonary edema, potentially caused by cytokine release syndrome, which can lead to shock if followed by fluid retention.
Increased risk of serious infection that could lead to sepsis if combined with other immune suppressants.
Nursing Considerations for Immune Suppressants
Monitoring:
Routine lab work: Specifically monitor renal and liver function, and white blood cell count.
Cardiac changes.
Acute reactions: Watch for symptoms beyond flu-like, such as a cough after infusion begins (sign of throat edema, requiring quick intervention).
Assessment Before Administration: Inquire about any active infections or if the patient is taking antibiotics.
Implementation:
Ensure regular lab work is completed.
Provide thorough patient education on proper injection technique to the patient and any assisting family members; observe self-administration to verify understanding.
Follow correct aseptic technique for all invasive procedures in these immunocompromised patients.
Educate patients on the increased risk of infection and how to mitigate it.
Make patients aware of common adverse effects and how to acquire adequate support during treatment.
Emphasize the importance of using barrier methods (condoms), not just hormonal birth control.
More informed patients are more likely to be compliant with treatment, safer, and this also protects the healthcare provider's license.
Evaluation:
Assess the effectiveness of patient teaching and review material if necessary.
Keep track of the severity of adverse effects.
Review lab work to ensure the treatment is not compromising other body systems.